A Study to Evaluate the Effects on QT/QTc Interval of TS-142 in Healthy Adult Subjects
Latest Information Update: 15 Oct 2021
At a glance
- Drugs Vornorexant (Primary) ; Moxifloxacin
- Indications Insomnia; Sleep apnoea syndrome
- Focus Pharmacodynamics
- Sponsors Taisho Pharmaceutical
- 11 Oct 2021 Status changed from recruiting to completed.
- 10 Jun 2021 Status changed from not yet recruiting to recruiting.
- 07 May 2021 New trial record